Global 3D Bioprinting Market to Reach US$ 4,281.9 Million by 2032, Bolstered by Technological Advancements

The latest report by IMARC Group, titled “3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2024-2032,” finds that the global 3D bioprinting market reached a value of US$ 1,205.8 Million in 2023. 3D bioprinting refers to the medical application of 3D printers for fabricating biological tissues and organs through the layering of living cells. It creates spatially-controlled patterns in 3D where viability and cell function are conserved within the printed construct. 3D bioprinting utilizes a layer-by-layer method to deposit materials like bio-inks. Bio-inks are obtained from living cells, biomaterials, and active biomolecules to create the 3D structure of tissues and organs. The technology offers speedy and accurate drug testing as potential drug compounds can be tested on bio-printed tissue before being used in human trials. It is also used to build complex bodily structures, including bones, skin, vascular grafts, tracheal splints, heart tissues, and cartilages. As a result, 3D bioprinting finds applications in the research and development of drugs, scaffolds, and medical implants.

Global 3D Bioprinting Market Trends: 

The market is primarily driven by the increasing geriatric population and rising instances of respiratory and cardiovascular diseases that require organ transplants. The limited number of organ donors is propelling the demand for 3D bioprinting across healthcare organizations. In addition to this, the technology is used in cosmetic surgeries and the pharmaceutical industry, further supplementing the market growth. This has also resulted in growing public and private fundings, which have prompted market players to improve and strengthen their manufacturing and distribution capabilities. As a result, 3D bioprinting is used to create simple tissue structures in a lab setting; however, it can also build complete organs for transplants in the future, owing to technological advancements and the manufacturing of customized products. Moreover, manufacturers have introduced organ-on-a-chip and bio-printed structures that enable a 3D in-vitro analysis of bodily functions and aids in developing artificial organs and tissues. Furthermore, extensive R&D investments and increasing stem cell research have increased awareness regarding 3D bioprinting, which is positively influencing the market growth. Looking forward, the market value is expected to reach US$ 4,281.9 Million by 2032, exhibiting a CAGR of 14.7% during the forecast period (2024-2032).

Market Summary: 

• Based on the component, the market has been segmented into 3D bioprinters (syringe/extrusion, inkjet, magnetic levitation, laser-assisted and other bioprinting), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices and others).
• On the basis of the application, the market has been classified into research (drug research, regenerative medicine and 3D cell culture) and clinical (skin, bone and cartilage, blood vessels and others).
• The market has been categorized based on the end user into hospitals, research organization and academic institutes and biopharmaceuticals companies.
• Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others) and Middle East and Africa.
• The competitive landscape of the market has been examined, with some of the key players being 3D Systems Inc., Aspect Biosystems Limited, Cellink AB, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH, Materialise NV, Organovo Holdings Inc., Poietis, regenHU Limited and Stratasys Limited.

Report Scope:

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal